The dataset Cosmetic Adverse Events is now available.

Complete Response Letters (CRL) issued in response to new drug applications (NDAs) and biologics license applications (BLAs) have been released. Currently, the database includes CRLs issued to sponsors as recently as 2025.

The dataset Drug Shortages is now available.

The dataset Historical Documents is now available.

All openFDA API endpoints may be queried using a "wildcard search". Click this link for more details.

The openFDA UDI API has been updated to include the Global Medical Device Nomenclature (GMDN) Code.

The dataset UNII is now available.

The openFDA system architecture has received a significant upgrade.

The openFDA data dictionary is now available.

Tobacco Problem Reports is now available via openFDA.

Drugs@FDA is now available via openFDA.

The new dataset "Independent Evaluations of COVID-19 Serological Tests" is available via openFDA.

The openFDA team is proud to announce that openFDA has now surpassed an astounding milestone: 200 million API calls.

We've expanded on our harmonization documentation, detailing which specific fields are harmonized.

The Substance Data endpoint is now available via openFDA.

The first openFDA animal drug dataset "Animal Drug Adverse Event Reports" is available via openFDA.

The NDC Directory is now available via openFDA.

openFDA is committed to transparency and always providing the best data available. This includes modifying released...

openFDA is committed to transparency and always providing the best data available. This includes modifying released...

Medicare Part D Prescription Drug Event Editing & Coverage Gap Discount Program

Since its launch in June 2014, the impetus for openFDA has been to make it easier for an application, mobile device...

Downloading full datasets has never been easier! Visit our central download page to download any and all openFDA datasets.

Transparency in the actions we take as an agency, and our reasons for taking them, is an important value for FDA in its...

Learn how others are using the openFDA data by exploring this graphical representation of openFDA data usage.

Community created apps can now be found directly on the openFDA website.

Read about the details of this newly available dataset and access the data through openFDA.

The Food and Drug Administration (FDA) is announcing a public workshop entitled: openFDA Public Workshop...

Since its launch in June 2014, the impetus for openFDA has been to make it easier to get access to publicly available FD...

openFDA is releasing information on medical devices that could spur innovation and advance scientific research...

The FDA created openFDA to make their public information about food, drugs, and devices more accessible and useful to de...

On May 22, 2015, Dr. Taha Kass-Hout gave an update on the openFDA project at the Big Data in Biomedicine conference at S...

The FDA is launching its very first openFDA challenge to the developer community to take advantage of the following data...

In addition to food and drugs, FDA has regulatory oversight of tens of thousands of medical devices ranging from bandage...

Every prescription drug (including biological drug products) approved by FDA for human use comes with FDA-approved label...

Every year, hundreds of human and animal foods, drugs, and medical devices are recalled from the market by manufacturers...

Welcome to the new home of openFDA! We are incredibly excited to see so much interest in our work and hope that this sit...

Today, I am pleased to announce the launch of openFDA, a new initiative from our Office of Informatics and Technology In...

FDA has established an Office of Informatics and Technology Innovation (OITI) under the Chief Health Informatics Officer...